Streetbeat News

Price Targets

ULTA

In the last 3 months, 16 analysts have offered 12-month price targets for Ulta Beauty (NASDAQ:ULTA), with an average price target of $588.94, a 7.49% increase from the previous average of $547.92. The company has received 4 bullish, 8 somewhat bullish, and 4 indifferent ratings.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 12:10 pm

QBTS

Benchmark analyst David Williams reiterated a Buy rating on D-Wave Quantum (NYSE:QBTS) and maintained a $2 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:09 pm

CTRN

Benchmark analyst John Lawrence reiterated a Buy rating on Citi Trends (NASDAQ:CTRN) and maintained a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:07 pm

CEG

Morgan Stanley analyst David Arcaro maintains an Overweight rating on Constellation Energy (NASDAQ:CEG) and raises the price target from $103 to $105.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:06 pm

ZM

Benchmark analyst Matthew Harrigan reiterates a Buy rating on Zoom Video Comms (NASDAQ:ZM) and maintains a $95 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:04 pm

ED

Morgan Stanley analyst David Arcaro maintains an Underweight rating on Consolidated Edison (NYSE:ED) and lowers the price target from $77 to $75.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:04 pm

CMS

Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on CMS Energy (NYSE:CMS) and lowers the price target from $65 to $63.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:03 pm

ATVI

Benchmark analyst Mike Hickey reiterates a Buy rating on Activision Blizzard (NASDAQ:ATVI) and maintains a $90 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:02 pm

CLF

Morgan Stanley analyst Carlos De Alba maintains an Overweight rating on Cleveland-Cliffs (NYSE:CLF) but lowers the price target from $24 to $19.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:02 pm

BHG

Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and raises the price target from $160 to $12,800.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:01 pm